Pegylated interferon alpha

This page covers all Pegylated interferon alpha drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Interferon-alpha receptor (IFNAR), Interferon alpha receptor (IFNAR).

Targets

Interferon-alpha receptor (IFNAR) · Interferon alpha receptor (IFNAR)

Marketed (1)

• PegIFN alfa-2a · The Second Affiliated Hospital of Chongqing Medical University · Immunology, Virology
  PegIFN alfa-2a is a pegylated interferon alpha-2a that activates innate immune responses by binding to interferon-alpha receptors on immune cells.

Phase 3 pipeline (2)

• Pegylated-Proline-interferon alpha-2b · AOP Orphan Pharmaceuticals AG · Virology/Hepatology
  Pegylated-Proline-interferon alpha-2b is a modified interferon alpha-2b with extended half-life that activates innate immune responses through interferon-alpha receptor signaling.
• Peg-P-IFN-alpha-2b (AOP2014) · AOP Orphan Pharmaceuticals AG · Virology / Immunology
  Peg-P-IFN-alpha-2b is a pegylated interferon alpha-2b that activates innate immune responses to suppress viral replication and enhance antiviral immunity.